Similar articles

• Fructosamine monitoring in patients with diabetes: is there a need?

  Henderson LO, Vogt RF Jr. Henderson LO, et al. Diabetes Technol Ther. 1999 Winter;1(4):461-2. doi: 10.1089/152091599317008. Diabetes Technol Ther. 1999. PMID: 11474833 No abstract available.
• Retrospective evaluation of the effect of trilostane on insulin requirement and fructosamine concentration in eight diabetic dogs with hyperadrenocorticism.

  McLauchlan G, Knottenbelt C, Augusto M, Helm J, McGrotty Y, Ramsey I. McLauchlan G, et al. J Small Anim Pract. 2010 Dec;51(12):642-8. doi: 10.1111/j.1748-5827.2010.01005.x. J Small Anim Pract. 2010. PMID: 21121919
• Fructosamine, III: Prologue or epitaph?

  Cembrowski GS. Cembrowski GS. Diabetes Technol Ther. 1999 Winter;1(4):457-9. doi: 10.1089/152091599316991. Diabetes Technol Ther. 1999. PMID: 11474832 No abstract available.
• Reference point: Exploring fructosamine beyond diabetes mellitus.

  Pattullo KM, Kidney BA. Pattullo KM, et al. J Am Vet Med Assoc. 2014 Jun 1;244(11):1268-77. doi: 10.2460/javma.244.11.1268. J Am Vet Med Assoc. 2014. PMID: 24846426 No abstract available.
• [Should the assay of fructosamine be part of the elements of diabetic monitoring?].

  Maugendre D, Dezier JF, le Treut A, Allannic H. Maugendre D, et al. Diabete Metab. 1990 Jan-Feb;16(1):55-8. Diabete Metab. 1990. PMID: 2185057 Review. French. No abstract available.